Fujian Cosunter Pharmaceutical Hits Day Low Amid Price Pressure at CNY 101.20

Fujian Cosunter Pharmaceutical Co., Ltd. experienced significant volatility on June 1, 2026, with the stock declining by 10.44% and reaching an intraday low of CNY 101.20. This performance starkly contrasts with the China Shanghai Composite, which saw a modest decline of 0.27% on the same day. Over the past week, Fujian Cosunter's stock has dropped 16.14%, and its monthly performance reflects a decrease of 13.51%. Despite these short-term challenges, the company has shown remarkable growth over the past year, boasting a 222.58% increase, significantly outperforming the Shanghai Composite's 21.22% gain. Financial metrics indicate that the company is currently facing operational difficulties, with a return on equity of -96.35% and a debt-equity ratio of 1.11. The company's net sales have grown at an annual rate of 3.58% over the last five years, while operating profit has seen a substantial decline. As a large-cap player in the pharmaceuticals and biotechnology sector, Fujian Cosunter's current market capitalization stands at CNY 16,311 million.